Boothbay Fund Management’s Immune Design Corp. IMDZ Stock Holding History

Boothbay Fund Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-27,122	Closed	-$159K	–	1022
2019 Q1	$159K	Hold	27,122	–	–	0.02%	628
2018 Q4	$35K	Sell	27,122 -416	-2%	-$723	0.01%	603
2018 Q3	$95K	Sell	27,538 -4,779	-15%	-$17.9K	0.01%	718
2018 Q2	$147K	Buy	+32,317	New	+$129K	0.01%	659

Boothbay Fund Management's IMDZ Position: Q2 2019 in Review

Boothbay Fund Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 27,122 shares — an estimated $159K sold.

Boothbay Fund Management first reported a position in IMDZ in Q2 2018 and held it in 4 quarters. The position peaked at $159K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Boothbay Fund Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Boothbay Fund Management sold 27,122 Immune Design Corp. shares in Q2 2019, an estimated $159K.
Boothbay Fund Management first reported a position in Immune Design Corp. in Q2 2018 and held it in 4 quarters.
Boothbay Fund Management's Immune Design Corp. position peaked at $159K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Boothbay Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.